Literature DB >> 10690721

In vivo proton magnetic resonance spectroscopy of central neurocytomas.

D G Kim1, W J Choe, K H Chang, I C Song, M H Han, H W Jung, B K Cho.   

Abstract

OBJECTIVE: The authors report on the metabolic features of central neurocytomas observed during in vivo single-voxel proton magnetic resonance spectroscopy.
METHODS: Volume-selective single-voxel proton magnetic resonance spectroscopy was performed with a 1.5-T unit using a point-resolved spectroscopy sequence (TR/TE = 2000 ms/135 and 270 ms) to obtain spectra of a single 8-cc voxel. The subjects were five patients in the Department of Neurosurgery of Seoul National University Hospital whose central neurocytomas had been diagnosed histologically. The peak intensities of compounds containing choline (Cho), N-acetylaspartate, creatine/phosphocreatine, and lactate were analyzed.
RESULTS: The ratios of Cho to creatine/phosphocreatine and Cho to N-acetylaspartate were significantly higher than ratios in normal brains. A lactate signal was present, and an unidentified signal was also observed at 3.55 ppm, which might have been produced by inositol or glycine.
CONCLUSION: A combination of the signal at 3.55 ppm and a prominent Cho peak seems to be a characteristic feature of central neurocytomas. Volume-selective single-voxel proton magnetic resonance spectroscopy could provide additional information to aid in diagnosing this condition.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10690721     DOI: 10.1097/00006123-200002000-00013

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  14 in total

Review 1.  Neurocytoma: a comprehensive review.

Authors:  Mehar Chand Sharma; Prabal Deb; Suash Sharma; Chitra Sarkar
Journal:  Neurosurg Rev       Date:  2006-08-29       Impact factor: 3.042

2.  Clinical course of central neurocytoma with malignant transformation-an indication for craniospinal irradiation.

Authors:  Petra Mozes; Erika Szanto; Laszlo Tiszlavicz; Pal Barzo; Adrienne Cserhati; Emese Fodor; Katalin Hideghety
Journal:  Pathol Oncol Res       Date:  2013-10-12       Impact factor: 3.201

3.  Linear accelerator radiosurgery for central neurocytoma: a case report.

Authors:  Chae-Yong Kim; Sun Ha Paek; Dong Gyu Kim
Journal:  J Neurooncol       Date:  2003-02       Impact factor: 4.130

4.  Demonstration of glycine peaks at 3.50 ppm in a patient with van der Knaap syndrome.

Authors:  R N Sener
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

5.  Central neurocytoma: a novel appraisal of a polymorphic pathology. Our experience and a review of the literature.

Authors:  Jacopo Lenzi; Maurizio Salvati; Antonino Raco; Alessandro Frati; Manolo Piccirilli; Roberto Delfini
Journal:  Neurosurg Rev       Date:  2006-04-08       Impact factor: 3.042

6.  In vivo proton magnetic resonance spectroscopy of intraventricular tumours of the brain.

Authors:  Carles Majós; Carles Aguilera; Mònica Cos; Angels Camins; Ana P Candiota; Teresa Delgado-Goñi; Alex Samitier; Sara Castañer; Juan J Sánchez; David Mato; Juan J Acebes; Carles Arús
Journal:  Eur Radiol       Date:  2009-03-11       Impact factor: 5.315

7.  Central neurocytoma: a clinical, radiological and pathological study of nine cases.

Authors:  Chun-Lin Chen; Chiung-Chyi Shen; John Wang; Ching-Hsiang Lu; Hsu-Tung Lee
Journal:  Clin Neurol Neurosurg       Date:  2007-11-26       Impact factor: 1.876

Review 8.  Central neurocytoma: a review.

Authors:  Meic H Schmidt; Oren N Gottfried; Cornelia S von Koch; Susan M Chang; Michael W McDermott
Journal:  J Neurooncol       Date:  2004-02       Impact factor: 4.130

9.  Central neurocytoma: the neuroradiological perspective.

Authors:  M Kerkovský; K Zitterbart; K Svoboda; J Hrivnacká; J Skotáková; A Sprláková-Puková; M Mechl
Journal:  Childs Nerv Syst       Date:  2008-05-31       Impact factor: 1.475

10.  Alanine peak in central neurocytomas on proton MR spectroscopy.

Authors:  T Krishnamoorthy; V V Radhakrishnan; B Thomas; E R Jeyadevan; G Menon; Suresh Nair
Journal:  Neuroradiology       Date:  2007-03-16       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.